Hospital & Pre-Hospital External Defibrillator Market - Forecast(2024 - 2030)

Hospital & Pre-Hospital External Defibrillator Market size is estimated to reach $4.3 billion by 2027, growing at a CAGR of 6.2% during the forecast period 2022-2027. Hospital & Pre-Hospital External Defibrillator includes a device that brings back a normal heartbeat by transmitting an electric pulse or shock to the heart. It is utilized to avert or correct an arrhythmia, a heartbeat that is irregular or that is too sluggish or too quick. Defibrillators can also bring back the heart’s beating if the heart unexpectedly halts. Pre-shock cardiopulmonary resuscitation may be advantageous for the survival of out-of-hospital cardiac patients with ventricular fibrillation / ventricular tachycardia in a post-hoc investigation of a prehospital trial conducted in Europe (L.Wik,2002). However, its efficiency in the Asian countries, where the most firstly reported rhythm in out-of-hospital cardiac arrests patients was asystole/pulseless electric activity rather than ventricular fibrillation / ventricular tachycardia, was not investigated so far. Wearable cardioverter defibrillators are automatic external defibrillators that supervise and treat a patient for ventricular defibrillation. The devices are aimed to be worn at home or in hospital settings as prescribed and directed by a doctor. Heart rhythms that may need defibrillation are ventricular tachycardia without a pulse, ventricular fibrillation, and cardiac arrest. Defibrillation can be performed by utilizing an automated external defibrillator (AED), a semi-automated defibrillator, or an internal cardiac defibrillator.

The surging application of external defibrillators including wearable cardioverter defibrillators in life-alarming conditions like ventricular fibrillation and cardiac arrhythmia is set to drive the Hospital & Pre-Hospital External Defibrillator Market. The surging technological progress in the field of external defibrillators and training and awareness programs targeted toward defibrillators is set to propel the growth of the Hospital & Pre-Hospital External Defibrillator Market during the forecast period 2022-2027. This represents the Hospital & Pre-Hospital External Defibrillator Industry Outlook.

Report Coverage

The report: “Hospital & Pre-Hospital External Defibrillator Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the Hospital & Pre-Hospital External Defibrillator Market.

By Product Type: Manual External Defibrillator, Automated External Defibrillator.
By End-User: Hospital (General Wards, ICU (Intensive Care Unit), Emergency Room, Others), Pre-Hospital (EMS (Emergency Medical Services), Fire Department, Police, Private Transport Companies, Others).
By Geography: North America (U.S, Canada and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia, Rest of South America), and Rest Of The World (Middle East, Africa).

Key Takeaways

• Geographically, North America Hospital & Pre-Hospital External Defibrillator Market accounted for the highest revenue share in 2021 and it is poised to dominate the market over the period 2022-2027 owing to the expanding population of senior citizens and the soaring government expenditure on healthcare facilities involving wearable cardioverter defibrillators in the North American region.
• Hospital & Pre-Hospital External Defibrillator Market growth is being driven by the increased hazard of cardiovascular diseases (CVDs) encountered by the elderly resulting in increased demand for hospital & pre-hospital external defibrillators including wearable cardioverter defibrillators. However, the restricted insurance coverage and the soaring cost of defibrillators are some of the major factors hampering the growth of the Hospital & Pre-Hospital External Defibrillator Market. 
• Hospital & Pre-Hospital External Defibrillator Market Detailed Analysis of the Strength, Weaknesses, and Opportunities of the prominent players operating in the market will be provided in the Hospital & Pre-Hospital External Defibrillator Market report.

The Hospital & Pre-Hospital External Defibrillator Market based on product type can be further segmented into Manual External Defibrillator and Automated External Defibrillator. The Manual External Defibrillator Segment held the largest market share in 2021. This growth is owing to the surging application of a manual external defibrillator for restarting a heart that has halted owing to conditions like ventricular fibrillation and ventricular tachycardia. The treatment for ventricular fibrillation and other life-alarming arrhythmias (abnormal heart rhythms) is defibrillation. The proliferating count of specialized and skilled healthcare professionals is further propelling the growth of the Manual External Defibrillator segment.

Furthermore, the Automated External Defibrillator segment is estimated to grow with the fastest CAGR of 7.6% during the forecast period 2022-2027 owing to the surging acceptance of automated external defibrillators for treating irregular heart rhythms, the expanding initiatives by principal firms and the deployment of numerous public access defibrillation programs.

Hospital & Pre-Hospital External Defibrillator Market Segment Analysis – By End-User:

The Hospital & Pre-Hospital External Defibrillator Market based on end-user can be further segmented into Hospital and Pre-Hospital. The Hospital segment held the largest market share in 2021. This growth is owing to the surging application of automated external defibrillators in in-hospital emergency management. Wearable cardioverter defibrillators are automatic external defibrillators that supervise and treat a patient for ventricular defibrillation to be worn at home or in hospital settings as prescribed and directed by a doctor. The proliferating count of hospitals is further propelling the growth of this segment.

Furthermore, the Pre-Hospital segment is estimated to grow with the fastest CAGR of 7.9% during the forecast period 2022-2027 owing to the extensive application of defibrillation involving utilization of defibrillation pads for pre-hospital defibrillation apart from the application of wearable cardioverter defibrillators at home and in hospital settings.

Hospital & Pre-Hospital External Defibrillator Market Segment Analysis – By Geography:

The Hospital & Pre-Hospital External Defibrillator Market based on geography can be further segmented into North America, Europe, Asia-Pacific, South America and Rest of the World. North America (Hospital & Pre-Hospital External Defibrillator Market) held the largest share with 33% of the overall market in 2021. The growth of this region is owing to the increasing predominance of cardiovascular diseases in the North American region. LifeVest® is FDA-approved and is categorized under wearable cardioverter defibrillators (WCDs) indicated to decrease the hazard of sudden cardiac death (SCD) in patients with decreased left ventricular ejection fraction (LVEF) who have endured an acute myocardial infarction (AMI). The novel product launches and the rising count of key players in the region are further propelling the growth of the Hospital & Pre-Hospital External Defibrillator Market in the North American region.

Furthermore, the Asia-Pacific region is estimated to be the region with the fastest CAGR rate over the forecast period 2022-2027. This growth is owing to factors like the proliferating lucrative opportunities offered in the Asia-Pacific region. The heightening application of defibrillators to treat irregular heart rhythms and the increasing predominance of heart failures are further fuelling the progress of the Hospital & Pre-Hospital External Defibrillator Market in the Asia-Pacific region.

Hospital & Pre-Hospital External Defibrillator Market Drivers

Surging Approvals Of Wearable Cardioverter Defibrillators Are Projected To Drive The Growth Of Hospital & Pre-Hospital External Defibrillator Market:

In the U.S., around 800,000 people have implantable cardioverter defibrillators (ICDs). 10,000 ICDs are implanted every month. The WEARABLE CARDIOVERTER DEFIBRILLATOR (WCD) 2000 LIFEVEST developed by ZOLL MANUFACTURING CORPORATION received premarket approval from the U.S. Food And Drug Administration (FDA) in 2001 to be utilized for adult patients who encountered the hazard of sudden cardiac arrest and either are not candidates for or decline an implantable defibrillator. Furthermore, in December 2015, the U.S. Food And Drug Administration (FDA) authorized the LifeVest wearable cardiovascular defibrillator (Zoll Manufacturing Corporation) for pediatric application. As per the FDA statement, “The LifeVest is approved for certain children who are at risk for sudden cardiac arrest, but are not candidates for an implantable defibrillator due to certain medical conditions or lack of parental consent". The LifeVest® wearable cardioverter defibrillator (WCD) is planned to safeguard patients from the hazard of sudden cardiac death (SCD), when a patient’s condition is altering and permanent SCD hazard has not been confirmed. The surging approvals of Wearable Cardioverter Defibrillators are therefore fuelling the growth of the Hospital & Pre-Hospital External Defibrillator Market during the forecast period 2022-2027.

Extensive Applications Of Defibrillators In Measuring Heart Rhythms Are Expected To Boost The Demand For Hospital & Pre-Hospital External Defibrillators:

There are three kinds of defibrillators namely Automated External Defibrillators (AEDs), Implantable Cardioverter Defibrillators (ICDs), and Wearable Cardioverter Defibrillators (WCDs). If a defibrillator is utilized within 3-5 minutes of cardiac arrest, survival rates jump from 6 percent to 74 percent. Every kind performs by inspecting for arrhythmias or uneven heart rhythms. Defibrillators are devices that re-establish a normal heartbeat by transmitting an electric pulse or shock to the heart. They are utilized to avert or correct an arrhythmia, a heartbeat that is uneven or that is too slow or too fast. Defibrillators can also bring back the heart’s beating if the heart unexpectedly halts. Distinct kinds of defibrillators perform in different ways. Automated external defibrillators (AEDs), which are in numerous public spaces, were developed to rescue the lives of people experiencing sudden cardiac arrest. Even untrained bystanders can use these devices in an emergency. Additional defibrillators can avert abrupt demise amidst people who have a soaring hazard of a life-alarming arrhythmia. They involve implantable cardioverter defibrillators (ICDs), which are surgically established within the body, and wearable cardioverter defibrillators (WCDs), which rest on the body. It can consume time and effort to get accustomed to living with a defibrillator, and it is vital to be aware of probable hazards and complexities. The extensive applications of defibrillators in measuring heart rhythms are therefore driving the growth of the Hospital & Pre-Hospital External Defibrillator Market during the forecast period 2022-2027.

Hospital & Pre-Hospital External Defibrillator Market Challenges

Disadvantages Of Defibrillators Are Hampering The Growth Of The Hospital & Pre-Hospital External Defibrillator Market:

Defibrillators are high-priced machines, with even the most modestly-priced home models surpassing the £650 mark. A LifeVest comes under the category of wearable cardioverter defibrillators developed by ZOLL Medical Corporation, which costs around $2,000. There may be added costs related to the fitting of the device and follow-up visits with a healthcare professional. The wearable cardioverter defibrillator is a lightweight and inconspicuous garment that can rescue lives. Additionally, most health insurance will not pay for a home automated external defibrillator (AED), putting the complete stress of the cost on the individual. Defibrillators in hospitals are even more costly but are more repeatedly utilized. AEDs need training to be utilized correctly. The owner’s manual comes with just the basics. Therefore, anyone who is required to utilize an AED needs to attend a training seminar. For hospital employees, defibrillator training takes time away from additional areas of learning. Improper application of a defibrillator can result in severe injury to the victim or onlookers in the immediate area. The extensive application of home and public defibrillators raises legal problems also. These issues are thus hampering the growth of the Hospital & Pre-Hospital External Defibrillator Market.

Hospital & Pre-Hospital External Defibrillator Industry Outlook:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Hospital & Pre-Hospital External Defibrillator Market. Key companies in this market are:

1. Medtronic PLC
2. Abbott (St. Jude Medical, Inc.)
3. Boston Scientific Corporation
4. BIOTRONIK SE & Co. KG
5. LivaNova PLC
6. Koninklijke Philips N.V.
7. ZOLL Medical Corporation
8. Stryker Corporation
9. Physio-Control, Inc.
10. Nihon Kohden Corporation

Recent Developments

• In July 2020, Royal Philips declared the introduction of its remote monitoring and defibrillator solution (Tempus ALS) for pre-hospital settings in the U.S. The solution is an entire end-to-end system that integrates creative hardware and progressive software to extend the pre-hospital scope of care for the earliest responders. The professional defibrillator (Tempus LS-Manual) is the ultimate element of the complete solution to accept 510(k) clearance from the U.S. Food and Drug Administration (FDA) and is presently accessible for sale in the U.S. market.
• In June 2020, Asahi Kasei Corporation upgraded its Zoll AED 3 defibrillator with real CPR help and integrated child rescue and wireless connectivity features.
• In September 2019, the BeneHeart C Series AED was launched by Shenzhen Mindray Bio-Medical Electronics Co. Ltd. for improving resuscitation during SCA cases. The device makes use of the ResQNavi technology for directing users through the rescue process and provides step-by-step voice prompts and animation coaching.

Related Reports:

Hospital Linen Supply & Management Services Market – Forecast (2022 - 2027)

Report Code: HCR 0417

Hospital Lighting Market – Forecast (2022 - 2027)

Report Code: ESR 0150

Hospital Supplies Market – Forecast (2022 - 2027)

Report Code: HCR 0180 

For more Lifesciences and Healthcare Market reports, please click here